SCHEMBL6083129

SCHEMBL6083129

COc1cc(Cl)c(-c2cc[nH]c(=O)c2[N+](=O)[O-])cc1F

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRIN2D O15399 3/20 0.38
GRIN3B O60391 3/20 0.38
GRIN1 Q05586 3/20 0.38
GRIN2A Q12879 3/20 0.38
GRIN2B Q13224 3/20 0.38
GRIN2C Q14957 3/20 0.38
GRIN3A Q8TCU5 3/20 0.38
KDM4E B2RXH2 2/20 0.37
MAPT P10636 2/20 0.37
BLM P54132 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
SCN8A Q9UQD0 3/20 0.37
SCN10A Q9Y5Y9 3/20 0.37
SMN1; SMN2 Q16637 1/20 0.35
PTGS2 P35354 2/20 0.34
LMNA P02545 1/20 0.34
CCNE1 P24864 1/20 0.34
CDK2 P24941 1/20 0.34
KMT2A Q03164 2/20 0.33
PTGS1 P23219 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoromethanesulfonic Acid SCHEMBL6082447 0.91 SCN8A (0.34) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL6082349 0.87 GRIN2D (0.38) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL6082365 0.87 GRIN2D (0.38) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL6082325 0.81 PTGS2 (0.34) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL6082332 0.80 GRIN2D (0.38) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL6083149 0.79 MAPT (0.46) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL6081876 0.74 TSHR (0.44) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL6083242 0.72 ABCC8 (0.42) TDP1KMT2AALDH1A1MEN1
SCHEMBL6082451 0.71 PTGS2 (0.33) MAPTSMN1; SMN2PTGS2LMNACDK2
SCHEMBL6082164 0.69 CCNT1 (0.36) KDM4EPTGS2KMT2APTGS1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7067658-B2 Pyridino and pyrimidino pyrazinones BRISTOL-MYERS SQUIBB COMPANY (US) 2006-06-27 US disclosed
US-20040082784-A1 Pyridino and pyrimidino pyrazinones BRISTOL-MYERS SQUIBB PHARMA COMPANY 2004-04-29 US disclosed
WO-2004031189-A1 PYRIDINO AND PYRIMIDINO PYRAZINONES FOR TREATMENT OF ANXIETY AND DEPRESSION BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) 2004-04-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040082784-A1 Pyridino and pyrimidino pyrazinones CRHR1, CRHR2, CRH GRIN2D 209/4885GRIN3B 123/4885GRIN1 113/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.